Latest news
FDA panel to review Grail's blood-based cancer test - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 21:32:11 GMTUS FDA to hold advisory meeting to review Grail's multi-cancer test - ReutersReuters · Fri, 07 Aug 2026 18:51:34 GMTFDA sets advisory panel for Galleri multicancer screening test - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 17:39:34 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTGRAIL to face FDA AdCom for Galleri cancer test (GRAL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 15:43:36 GMTFDA panel to review GRAIL’s cancer detection test on Sept. 23 - Investing.com CanadaInvesting.com Canada · Fri, 07 Aug 2026 15:13:16 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMTCancer Detection Test Receives Regulatory Marking for Use in Great Britain - Clinical Lab ProductsClinical Lab Products · Fri, 07 Aug 2026 13:39:57 GMT